R Schmits1, B Glass, L Trümper, M Pfreundschuh. Show Affiliations » 1. Dept. of Medicine, Saarland University Schooel of Medicine, Homburg/Saar, Germany.
Abstract
Entities: Disease
Mesh： See more » AdolescentAdultAge FactorsAgedAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useClinical Trials as TopicCombined Modality TherapyCyclophosphamide/administration & dosageDose-Response Relationship, DrugDoxorubicin/administration & dosageFemaleGermanyHumansImmunotherapyInternational CooperationLymphoma, Non-Hodgkin/classificationLymphoma, Non-Hodgkin/drug therapyLymphoma, Non-Hodgkin/mortalityLymphoma, Non-Hodgkin/pathologyLymphoma, Non-Hodgkin/therapyMaleMiddle AgedPrednisone/administration & dosagePrognosisRadiotherapy, AdjuvantRemission InductionRisk FactorsRituximabSeverity of Illness IndexTreatment OutcomeVincristine/administration & dosage
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedRituximabVincristineDoxorubicinCyclophosphamidePrednisone
Year: 2001 PMID： 11757714 DOI： 10.1007/pl00022796
Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 3.673